ESC 365 - Increased plasma ACE2 activity is a marker of subclinical LV systolic dysfunction in patients with aortic stenosis.

ESC Premium Access

Increased plasma ACE2 activity is a marker of subclinical LV systolic dysfunction in patients with aortic stenosis.

Session: Poster session 3 - Impact of new parameters on aortic stenosis outcomes

Topic: Aortic valve disease

Speaker: Doctor J. Ramchand (Cleveland, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Jay Ramchand

Cleveland Clinic Foundation, Cleveland (United States of America)

0 follower

11 more presentations in this session

The effect of age on the prevalence of aortic stenosis in a large retrospective echocardiographic study

Speaker: Doctor S. Tyebally (London, GB)

Prevalence and lifetime risk factors for aortic stenosis in a general population of middle aged men in Sweden with 21 years follow up.

Speaker: Associate Professor E. Thunstrom (Gothenburg, SE)

Impact of baseline left-ventricular ejection fraction on 30-day and 1-year outcome after transfemoral aortic valve implantation: Interaction with mean gradient across the aortic valve

Speaker: Doctor K. El Chilali (Recklinghausen, DE)

Global radiological exposure of TAVI: an unresolved issue with potential drawbacks in low and intermediate risk patients

Speaker: Doctor L. Biasco (Cirie, IT)

Impact of myocardial fibrosis on 10-year-outcome in patients undergoing aortic valve replacement

Speaker: Doctor S. Herrmann (Bad Mergentheim, DE)

Access the full session

Poster session 3 - Impact of new parameters on aortic stenosis outcomes

Speakers: Doctor J. Ramchand, Doctor S. Tyebally, Associate Professor E. Thunstrom, Doctor K. El Chilali, Doctor L. Biasco...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources